Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, 410000, China.
Department of Digestive Oncology, Tongji Shanxi Hospital, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030032, China.
Lipids Health Dis. 2024 Apr 2;23(1):96. doi: 10.1186/s12944-024-02093-1.
BACKGROUND: Guidelines on coronary intermediate lesions strongly recommend deferred revascularization after detecting a normal fractional flow reserve (FFR). Researches about triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) on cardiovascular diseases has also been well conducted. However, the association of TG/HDL-C and long-term adverse clinical outcomes remains unknown for patients deferred revascularization following FFR. METHODS: This study retrospectively included 374 coronary artery disease (CAD) patients with non-significant coronary lesions diagnosed by coronary angiography (CAG) and FFR. The main outcome measure was the combination of major adverse cardiovascular and cerebrovascular events (MACCEs). All patients were categorized into three subgroups in terms of TG/HDL-C tertiles (T1 < 0.96, 0.96 ≤ T2 < 1.58, T3 ≥ 1.58). Three different Cox regression models were utilized to reveal the association between TG/HDL-C and prevalence of MACCEs. RESULTS: 47 MACCEs were recorded throughout a median monitoring period of 6.6 years. The Kaplan-Meier survival curves showed a higher MACCEs rate occurred in the higher TG/HDL-C group (5.6% vs. 12.9% vs. 19.4%, log-rank P < 0.01). After adjustment, patients in T3 suffered a 2.6-fold risk compared to the T1 group (T3 vs. T1: HR 2.55, 95% CI 1.05-6.21, P = 0.038; T2 vs. T1: HR 1.71, 95% CI 0.65-4.49, P = 0.075; P for trend = 0.001). The restricted cubic spline (RCS) analysis demonstrated that the HR for MACCEs rose as TG/HDL-C increased. Both the receiver operating characteristic (ROC) and time-dependent ROC proved the excellent predictive ability of TG/HDL-C. CONCLUSION: The study illustrates that TG/HDL-C correlates with the risk of MACCEs in CAD patients deferred revascularization following FFR. TG/HDL-C could serve as a dependable predictor of cardiovascular events over the long term in this population.
背景:关于冠状动脉中间病变的指南强烈建议在检测到正常的血流储备分数(FFR)后延迟血运重建。关于甘油三酯与高密度脂蛋白胆固醇(TG/HDL-C)与心血管疾病的关系的研究也已经进行得很好。然而,对于接受 FFR 后延迟血运重建的患者,TG/HDL-C 与长期不良临床结局之间的关联尚不清楚。
方法:本研究回顾性纳入了 374 名因冠状动脉造影(CAG)和 FFR 诊断为非显著性冠状动脉病变的冠心病(CAD)患者。主要观察终点为主要不良心血管和脑血管事件(MACCEs)的组合。所有患者根据 TG/HDL-C 三分位(T1<0.96、0.96≤T2<1.58、T3≥1.58)分为三组。采用三种不同的 Cox 回归模型来揭示 TG/HDL-C 与 MACCEs 患病率之间的关系。
结果:在中位监测期为 6.6 年的过程中,记录了 47 例 MACCEs。Kaplan-Meier 生存曲线显示,TG/HDL-C 较高的患者 MACCEs 发生率更高(5.6%比 12.9%比 19.4%,对数秩 P<0.01)。调整后,T3 组患者的风险比 T1 组高 2.6 倍(T3 比 T1:HR 2.55,95%CI 1.05-6.21,P=0.038;T2 比 T1:HR 1.71,95%CI 0.65-4.49,P=0.075;P 趋势=0.001)。受限立方样条(RCS)分析表明,随着 TG/HDL-C 的增加,MACCEs 的 HR 也随之上升。ROC 和时间依赖性 ROC 均证明了 TG/HDL-C 的优异预测能力。
结论:本研究表明,在接受 FFR 后延迟血运重建的 CAD 患者中,TG/HDL-C 与 MACCEs 的风险相关。在该人群中,TG/HDL-C 可作为长期心血管事件的可靠预测指标。
JACC Cardiovasc Interv. 2017-11-29
Catheter Cardiovasc Interv. 2021-2-1
Ann Intern Med. 2023-6
J Am Coll Cardiol. 2023-4-25
Biomolecules. 2023-1-4
N Engl J Med. 2022-11-24